BALLANTYNE JOHN has filed 9 insider transactions across 1 company since July 2024.
Most recent transaction: a transaction of 132036 shares of Glucotrack, Inc. ($GCTK) on November 14, 2024.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | BALLANTYNE JOHN | Director | J | Common Stock, par value $0.001 per share | 132036 | $31.00 | 187,165.0000 | 0 | 239.50% | 0.00% |
| March 12, 2025 | Glucotrack, Inc. | $GCTK | BALLANTYNE JOHN | Director | X | Common Stock, par value $0.001 per share | 2560553 | $0.00 | 2,747,717.0000 | 0 | 1368.08% | 0.00% |
| March 26, 2025 | Glucotrack, Inc. | $GCTK | BALLANTYNE JOHN | Director | A | Common Stock, par value $0.001 per share | 4126 | $0.00 | 2,747,717.0000 | 0 | 0.15% | 0.00% |
| July 30, 2024 | Glucotrack, Inc. | $GCTK | BALLANTYNE JOHN | Director | P | Warrants to Purchase Common Stock | 106667 | $0.00 | 106,667.0000 | 0 | 9999.99% | 0.00% |
| July 30, 2024 | Glucotrack, Inc. | $GCTK | BALLANTYNE JOHN | Director | P | Warrants to Purchase Common Stock | 76191 | $0.00 | 76,191.0000 | 0 | 9999.99% | 0.00% |
| July 30, 2024 | Glucotrack, Inc. | $GCTK | BALLANTYNE JOHN | Director | P | Warrants to Purchase Common Stock | 59260 | $0.00 | 59,260.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | BALLANTYNE JOHN | Director | A | Series A Common Warrant | 132036 | $0.00 | 132,036.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | BALLANTYNE JOHN | Director | A | Series B Common Warrant | 132036 | $0.00 | 132,036.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2025 | Glucotrack, Inc. | $GCTK | BALLANTYNE JOHN | Director | X | Series B Common Warrant | 132036 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |